- All
- 2026-06-11 [Thursday]
- 2026-06-12 [Friday]
- 2026-06-13 [Saturday]
- 2026-06-14 [Sunday]
- All
- A1-A (102-107)
- A1-A101
- A1-A102
- A1-A103
- A1-A104
- A1-A (105-107)
- A1-A108
- A1-A109
- A1-A110
- A2-A206
- A2-A207
- A2-A208
- A2-A213
- A2-A214
- A2-A215
- B1 Hall (Poster Area)
- B1 Hall (Exhibition Area)
2026-06-14 (Sunday)
A1-A109
| NO. | Time | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 08:00-08:06 |
Machine learning-based MRI radiomics in predicting survival after concurrent TACE with Lenvatinib plus PD-1 inhibitors for unresectable HCC: a multicenter study |
Chi Zhang | Sichuan Cancer Hospital, China |
| 2 | 08:08-08:14 |
Lenvatinib and PD-1 inhibitors plus Hepatic Arterial Infusion Chemotherapy as First-line Treatment for Hepatocellular Carcinoma with High Tumor Burden and Portal Vein Tumor Thrombus: a Target Trial Emulation Study (CHANCE 2416) |
Jia-Xi Liu | The First Affiliated Hospital of China Medical University, China |
| 3 | 08:16-08:22 |
Early Response Evaluation of Hepatocellular Carcinoma After Transarterial Chemoembolization Using Triphasic Computed Tomography |
Nasr ullah Yaqoob | Aria Institute of Medical Sciences Balochistan, Pakistan |
| 4 | 08:24-08:30 |
Balloon - TACE : Novel technique for enhanced drug deposition in HCC |
Aayush Mathur | AVBRH, India |
| 5 | 08:40-08:46 |
Pharmacokinetics of Idarubicin in Plasma and Liver Tissues of VX2 Hepatocellular Carcinoma Rabbits after Transarterial Chemoembolization with EqualSphere Drug-Eluting Microspheres |
Zhe-Yu Jiang | Affiliated Hospital of Guizhou Medical University, China |
